In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws.
Koneski, Filip; Popovic-Monevska, Danica; Gjorgoski, Icko; Krajoska, Jovanka; Popovska, Mirjana; Muratovska, Ilijana; Velickovski, Boris; Petrushevska, Gordana; Popovski, Vladimir.
J Craniomaxillofac Surg
; 46(2): 230-236, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29233701
Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis.
Preventive dental management of osteonecrosis of the jaws related to zoledronic acid treatment.
The role of dental care providers in the management of patients prescribed bisphosphonates: brief clinical guidance.
Treatment for bisphosphonate-related osteonecrosis of the jaw.
Current management concepts for bisphosphonate-related osteonecrosis of the jaw: a review.
Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
Retrospective study regarding the appearance of osteonecrosis related to bisphosphonate therapy.
Bisphosphonate Induced Osteonecrosis of the Jaws: Our Clinical Experience at King Hussein Medical Center, Amman, Jordan.
Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.